These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36644653)

  • 1. Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study.
    Mendel A; Fritzler MJ; St-Pierre Y; Rauch J; Bernatsky S; Vinet É
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100041. PubMed ID: 36644653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
    Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
    Front Immunol; 2022; 13():953043. PubMed ID: 36189273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.
    Taha M; Samavati L
    RMD Open; 2021 May; 7(2):. PubMed ID: 33958439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia.
    Bnina AB; Dhia RB; Gnaba S; Annabi A; Chouchane S; Naija W; Said H; Oueslati A; Bouatay A
    Pan Afr Med J; 2022; 42():110. PubMed ID: 36034019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2.
    Ogrič M; Žigon P; Sodin-Semrl S; Zlatković-Švenda M; Zdravković M; Ovuka M; Švec T; Lakota K; Radšel P; Rotar Ž; Čučnik S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
    Signorelli F; Balbi GGM; Aikawa NE; Silva CA; Kupa LVK; Medeiros-Ribeiro AC; Yuki EF; Pasoto SG; Saad CG; Borba EF; Seguro LPC; Pedrosa T; Oliveira VAA; Costa ALCS; Ribeiro CT; Santos REB; Andrade DCO; Bonfá E
    Lupus; 2022 Jul; 31(8):974-984. PubMed ID: 35593174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit.
    Hamadé A; Woehl B; Harzallah I; Talbot M; Tousch J; Jambert L
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):73-79. PubMed ID: 33273262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019.
    Serrano M; Espinosa G; Lalueza A; Bravo-Gallego LY; Diaz-Simón R; Garcinuño S; Gil-Etayo J; Moises J; Naranjo L; Prieto-González S; Ruiz-Ortiz E; Sánchez B; Moreno-Castaño AB; Díaz-Pedroche C; Viñas-Gomis O; Cervera R; Serrano A;
    ACR Open Rheumatol; 2021 Apr; 3(4):267-276. PubMed ID: 33738987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection.
    Espinosa G; Zamora-Martínez C; Pérez-Isidro A; Neto D; Bravo-Gallego LY; Prieto-González S; Viñas O; Moreno-Castaño AB; Ruiz-Ortiz E; Cervera R
    Front Immunol; 2022; 13():911979. PubMed ID: 35812410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre.
    Barilaro G; Coloma-Bazan E; Chacur A; Della Rocca C; Perez-Isidro A; Ruiz-Ortiz E; Viñas O; Tàssies Penella D; Reverter JC; Molina Andujar A; Cervera R; Espinosa G
    Autoimmun Rev; 2022 Dec; 21(12):103208. PubMed ID: 36202304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
    Favaloro EJ; Henry BM; Lippi G
    Semin Thromb Hemost; 2022 Feb; 48(1):72-92. PubMed ID: 34130340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid Antibodies Occurrence in Acute SARS-CoV-2 Infection without Overt Thrombosis.
    Dima A; Popescu DN; Moroti R; Stoica E; State G; Negoi F; Berza IA; Parvu M
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
    Demir S; Li J; Magder LS; Petri M
    Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.